Seeking a Cure for Sickly Corporate Governance at SinoVac

finance.yahoo.com/news/seeking-cure-sickly-corporate-governance-174123420.html

In This Article:
-
Chinese SinoVac Biotech Ltd. (Nasdaq: SVA) shares have been frozen since 2019 amid shareholder disputes when market cap was about $500 million
-
SinoVac developed a wildly successful Covid vaccine and has over $10 billion in cash on balance sheet but investors have had…

This story appeared on finance.yahoo.com, 2025-06-25 17:41:23.
The Entire Business World on a Single Page. Free to Use →